
Quintiles: Outsourcing biopharmaceutical development and commercial services for innovative therapies.
Quintiles specializes in biopharmaceutical development and commercial outsourcing services, aiding pharmaceutical, biotechnology, and medical device companies in bringing innovative therapies to market. The company is driven by the promise of medical breakthroughs that improve and save lives. Quintiles offers comprehensive support throughout the product lifecycle, including clinical trials, regulatory affairs, and market access. Their market focus spans globally, with operations in the Americas, Asia & Oceania, Europe, and the Middle East & Africa.
Quintiles has made significant contributions to the healthcare industry by facilitating the development and commercialization of numerous groundbreaking therapies. Their extensive global presence ensures they can support clients across various regions, adapting to local regulatory environments and market needs. The company's impact is evident in its role in advancing medical research and improving patient outcomes worldwide. Notable achievements include successful partnerships with leading pharmaceutical companies and a robust portfolio of completed clinical trials.

Catalent
catalent.com

Syneos Health
syneoshealth.com

Innovex

Medpace
medpace.com

Charles River Laboratories
criver.com

PharmaDirections

Societal Cdmo
societalcdmo.com

Novotech
novotech-cro.com
Bristol Myers Squibb
bms.com

IQVIA
iqvia.com

Lonza

ShangPharma

Royalty Pharma
royaltypharma.com

Kyntra Bio
fibrogen.com

KBI Biopharma
Companies similar to Quintiles include Catalent, Syneos Health, Innovex and Medpace.
Quintiles was founded in 1982.
Quintiles' headquarters is located in Durham, NC, US.
Quintiles' most recent funding round was for $1M (USD) in June 2013.
As of Jun 12, 2013, Quintiles has raised a total of $3.5B (USD).
Quintiles has 10,000 employees as of Feb 4, 2024.